OTC:ANEB | Income Statement | Anebulo Pharmaceuticals, Inc.

Complete source-backed income-statement history.

Available history
2020-09-30 to 2025-12-31
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$1.16M$2.62M-$2.62M$620,513.00-$2M-$0.05-$0.0541,084,73141,084,731
2025-09-30$809,991.00$2.26M-$2.26M$101,906.00-$2.16M-$0.05-$0.0541,084,73141,084,731
2025-06-30$1.13M$2.33M-$2.33M$186,056.00-$2.14M-$0.05-$0.052,412,6372,412,637
2025-03-31$638,324.00$1.89M-$1.89M$216,153.00-$1.68M-$0.04-$0.0441,084,73141,084,731
2024-12-31$1.22M$2.59M-$2.59M$125,121.00-$2.46M-$0.09-$0.0927,415,43027,415,430
2024-09-30$1.31M$2.41M-$2.41M$211,388.00-$2.2M-$0.08-$0.0825,933,21725,933,217
2024-06-30$467,706.00$1.34M-$1.34M-$9,602.00-$1.35M-$0.05-$0.0537,40537,405
2024-03-31$748,339.00$1.66M-$1.66M$10,709.00-$1.65M-$0.06-$0.0625,933,21725,933,217
2023-12-31$1.06M$2.76M-$2.76M$43,090.00-$2.72M-$0.11-$0.1125,789,73925,789,739
2023-09-30$1.27M$2.54M-$2.54M$62,855.00-$2.48M-$0.10-$0.1025,633,21725,633,217
2023-06-30$1.42M$2.49M-$2.49M-$1,191.00-$2.5M-$0.10-$0.10185,565185,565
2023-03-31$1.09M$2.86M-$2.86M$66,070.00-$2.8M-$0.11-$0.1125,633,21725,633,217
2022-12-31$1.87M$3.81M-$3.81M-$13,830.00-$3.83M-$0.15-$0.1525,633,21725,633,217
2022-09-30$1.22M$2.61M-$2.61M-$212.00-$2.61M-$0.11-$0.1123,416,49523,416,495
2022-06-30$1.12M$2.33M-$2.33M$2,742.00-$2.32M$0.480
2022-03-31$915,363.00$1.88M-$1.88M$3,153.00-$1.88M-$0.0823,344,567
2021-12-31$212,936.00$1.07M-$1.07M-$1.07M-$0.0523,344,56723,344,567
2021-09-30$715,098.00$1.55M-$1.55M$1,529.00-$1.55M-$1.55M-$0.0723,344,56723,344,567
2021-06-30$1.81M$2.48M-$2.48M-$26.63M-$2.47M-$29.11M956,391
2021-03-31$273,038.00$552,131.00-$552,131.00-$3,701.00-$555,832.00-$555,832.0012,982,500
2020-12-31$169,982.00$324,571.00-$324,571.00-$328,604.0012,982,500
2020-09-30$20,286.00$252,346.00-$4,033.00-$252,346.00-$256,379.0012,000,000

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-06-30$4.3M$9.22M-$9.22M$738,718.00-$8.48M-$0.25-$0.2533,820,30633,820,306
2024-06-30$3.55M$8.31M-$8.31M$107,052.00-$8.2M-$0.32-$0.3225,822,25825,822,258
2023-06-30$5.6M$11.78M-$11.78M$51,261.00-$11.73M-$0.47-$0.4725,074,48125,074,481
2022-06-30$2.96M$6.83M-$6.83M$5,555.00-$6.83M$0.29$0.2923,344,56723,344,567
2021-06-30$2.27M$3.61M-$3.61M-$26.64M-$3.61M-$30.25M-$2.8313,612,70113,612,701